Skip to main content

Emulation trials in SLE: Real or Fake? Recently a landmark paper was published in A&R studying the results of an e

Social Author Name
Dr. John Cush
Tweet Content
Emulation trials in SLE: Real or Fake? Recently a landmark paper was published in A&R studying the results of an emulation trial. My colleagues and I were able to write an editorial on this paper and describe emulation trials. https://t.co/0ulYG5xz0J https://t.co/y2jo2SSH83

Comparing EULAR (2025) and ACR (2020) Guidelines on Safety of Lupus Medications in Pregnancy Attendees at the 2025 Rhe

Social Author Name
Dr. John Cush
Tweet Content

Comparing EULAR (2025) and ACR (2020) Guidelines on Safety of Lupus Medications in Pregnancy Attendees at the 2025 RheumaPreg meeting were excited to discuss the newly released EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation. https://t.co/csd0FE08ZO

Risk Factors for Knee Osteoarthritis New research from the University of Sydney reveals that obesity, having a knee in

Social Author Name
Dr. John Cush
Tweet Content
Risk Factors for Knee Osteoarthritis New research from the University of Sydney reveals that obesity, having a knee injury and occupational risks such as shift work and lifting heavy loads are primary causes of knee osteoarthritis. https://t.co/Kc686Zc8Xa https://t.co/ANyiE2pIxo

New Steroid Rules in Lupus? Let’s Talk. Dr. Michelle Petri breaks down the latest strategies to minimize steroid expos

Social Author Name
Dr. John Cush
Tweet Content
New Steroid Rules in Lupus? Let’s Talk. Dr. Michelle Petri breaks down the latest strategies to minimize steroid exposure while managing disease activity in lupus patients. πŸ’‘ Smarter steroid use = better outcomes. πŸ‘‰ Watch now on RheumNow: https://t.co/vbjrXAlixz #Lupus https://t.co/TN5EkZhbef

πŸ”“ Lupus Unlocked: Antiphospholipid Syndrome πŸ“… Tuesday, May 20, 2025 | πŸ•• Time: 6:00 PM CT | 7:00 PM ET | 4:00 PM

Social Author Name
Dr. John Cush
Tweet Content
πŸ”“ Lupus Unlocked: Antiphospholipid Syndrome πŸ“… Tuesday, May 20, 2025 | πŸ•• Time: 6:00 PM CT | 7:00 PM ET | 4:00 PM PT Live Webinar w/ Q&A Register Today: https://t.co/71NJsmBNf3 Livestream: X, LinkedIn, YouTube, Facebook This session is designed to provide practical insights https://t.co/jAtduyzl0l

FDA approved the chikungunya virus vaccine (Ixchiq) in 11/23, but recently announced caution and pause use while it inve

Social Author Name
Dr. John Cush
Tweet Content
FDA approved the chikungunya virus vaccine (Ixchiq) in 11/23, but recently announced caution and pause use while it investigates Postmarketing Safety Reports of 17 SAE (cardiac & neurologic) & 2 deaths. 6 SAE in the USA, elderly w/ chronic med conditions. ~80K doses of Ixchiq https://t.co/RED8Xab0Ir

3-year, RCT of Mediteranean diet vs usual care in 924 older adults w/ metabolic syndrome & BMI > 27. Med. diet s

Social Author Name
Dr. John Cush
Tweet Content
3-year, RCT of Mediteranean diet vs usual care in 924 older adults w/ metabolic syndrome & BMI > 27. Med. diet shows signif wt loss (3.4% vs 0.4%), w/ improved BMD (by DEXA) at year 3, especially in women. https://t.co/mllx6l1QnM https://t.co/I5e8PXX2oX

Clinical Impacts of the Pre Lupus State on Pregnancy Outcomes Dr. Catherine Sims talks with Dr. Jessica English at the

Social Author Name
Dr. John Cush
Tweet Content
Clinical Impacts of the Pre Lupus State on Pregnancy Outcomes Dr. Catherine Sims talks with Dr. Jessica English at the RheumaPreg 2025 meeting in Vienna, Austria. https://t.co/T8ZYQtDNmZ https://t.co/PmVRFVlABd
Subscribe to
×